Bobby Tajudeen to Combined Modality Therapy
This is a "connection" page, showing publications Bobby Tajudeen has written about Combined Modality Therapy.
Connection Strength
0.523
-
Treatment Modalities and Survival Outcomes for Sinonasal Diffuse Large B-Cell Lymphoma. Laryngoscope. 2021 11; 131(11):E2727-E2735.
Score: 0.177
-
Prognostic indicators of survival in sinonasal extranodal natural killer/T-cell lymphoma. Laryngoscope. 2019 12; 129(12):2675-2680.
Score: 0.152
-
Epidemiologic, prognostic, and treatment factors in sinonasal diffuse large B -cell lymphoma. Laryngoscope. 2019 06; 129(6):1259-1264.
Score: 0.150
-
Laryngeal Chondrosarcoma Characteristics and Survival Analysis in the National Cancer Database. Otolaryngol Head Neck Surg. 2022 01; 166(1):101-108.
Score: 0.044